Medline ® Abstract for Reference 82
of 'Secondary factors and progression of chronic kidney disease'
82
TI
Interferon-gamma inhibits experimental renal fibrosis.
AU
Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM
SO
Kidney Int. 1999;56(6):2116.
UNLABELLED:
Interferon-gamma inhibits experimental renal fibrosis.
BACKGROUND:
Recent evidence has implicated myofibroblasts as a cell type responsible for the laying down of extracellular matrix components during fibrosis in a number of organs. In this study, we examined the capacity of interferon-gamma (IFN-gamma) to inhibit the activation of fibroblasts to the myofibroblastic phenotype and hence reduce the extent of renal scarring in the rat subtotal nephrectomy (SNx) model using a novel method of intrarenal delivery.
METHODS:
Rats were divided into four groups: sham, SNx (group 1), SNx + drug vehicle (group 2) and SNx + IFN-gamma (400 units/day; group 3) for 30 days. Rats were sacrificed on days 15, 30, 45, and 90 following SNx.
RESULTS:
Clinical data showed a marked reduction in proteinuria in the group treated with IFN-gamma (161 vs. 280 mg/24 hr by day 45, P<0.01) and a preservation of the creatinine clearance (1.16 vs. 0. 84 ml/min by day 45, P<0.05) when comparedto the SNx or SNx + vehicle groups throughout the time course. Immunohistochemical staining for alpha-smooth muscle actin (alpha-SMA) revealed a reduction in myofibroblastic cell types (6.5 +/- 3.1% glomerular alpha-SMA in group 3 compared with 14.8 +/- 4.2% glomerular alpha-SMA in group 2, P<0.05, 3.8 +/- 1.4% tubulointerstitial alpha-SMA in group 3 compared with 8.8 +/- 2.0% tubulointerstitial alpha-SMA in group 2 on day 45, P<0.05). There was also a reduction in immunostaining for collagens III and IV in the IFN-gamma-treated group. Scoring for both glomerulosclerosis and tubulointerstitial fibrosis in the IFN-gamma group (group 3) was lower than the other two operated groups.
CONCLUSIONS:
We conclude that IFN-gamma, administered at a dose of 400 units/day, has a strong inhibitory effect on myofibroblasts and that as a possible result of this action, renal fibrosis is reduced and renal function is preserved in the rat SNx model. The IFN-gamma renoprotective effect lasted only for the extent of its administration and subsided when discontinued.
AD
Division of Clinical Sciences NGH, Sheffield Kidney Institute, University of Sheffield, Northern General Hospital, England, United Kingdom. s.d.oldroyd@sheffield.ac.uk
PMID
